The management plan for a patient with Crohn's disease should take into account the
activity, site and behaviour of disease, and should always be discussed with the patient …

Autoimmune hepatitis is a rare and chronic liver disease that is characterised by increased
serum transaminases and immunoglobulin G, inflammatory liver histology and presence of …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALF, acute liver failure; ALT, alanine aminotransferase; AMA …

Guidelines for clinical practice are intended to suggest preferable approaches to particular
medical problems as established by interpretation and collation of scientifically valid …

This second section of the European Crohn's and Colitis Organisation (ECCO) Consensus
on the management of Crohn's disease concerns treatment of active disease, maintenance …

6-Mercaptopurine and its prodrug azathioprine remain the mainstay of immunomodulator
therapy for the maintenance of a steroid-free remission in patients with IBD. Recent …

The thiopurine drugs azathioprine and 6‐mercaptopurine (6‐MP) are well‐established in the
treatment of inflammatory bowel disease (IBD). However, there is a wide inter‐and intra …

Featuring more than 4100 references, Drug-Induced Liver Disease is an invaluable
reference for gastroenterologists, hepatologists, family physicians, internists, pathologists …

Background & Aims: Many IBD patients not responding to azathioprine (AZA) or 6-
mercaptopurine (6-MP) preferentially metabolize 6-MP to 6-methylmercaptopurine (6-MMP) …

The mean prevalence of azathioprine (AZA) or 6-mercaptopurine (MP)-induced liver injury in
patients with inflammatory bowel disease was approximately 3%, and the mean annual drug …